Current report filing

Document And Entity Information

Document And Entity Information
Jan. 30, 2024
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Document Period End Date Jan. 30, 2024
Entity Central Index Key 0001595097
Entity Emerging Growth Company false
Entity File Number 001-37348
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 46-4348039
Entity Address, Address Line One 500 River Ridge Drive
Entity Address, City or Town Norwood
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02062
City Area Code (617)
Local Phone Number 963-0100
Entity Information, Former Legal or Registered Name Not Applicable
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol CRBP
Security Exchange Name NONE
Amendment Description Corbus Pharmaceuticals Holdings, Inc. is filing this Amendment No. 1 to its Current Report on Form 8-K, originally filed with the Securities and Exchange Commission on February 1, 2024 (the "Original 8-K"), solely to re-file the opinion filed as Exhibit 5.1 to the Original 8-K to include the conformed signature, which was inadvertently omitted. The corrected opinion is filed as Exhibit 5.1 hereto and supersedes and replaces in its entirety the opinion filed as Exhibit 5.1 to the Original 8-K.